Arca Biopharma | ABIO - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Amgen USD 653M 94.99B 2026-09
Arca Biopharma USD 4.6M 4.1M 2026-03
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 403M 4M 2026-09
Capricor Therapeutics 3.05M 2.46M 2025-12
Cipla INR 167.4M 2.9M 2026-09
Compugen USD 1.84M 485K 2026-06
CSL USD 215M 111M 2025-12
Cytokinetics USD 38.48M 3.65M 2026-09
Daiichi Sankyo JPY 14.13B 10.56B 2026-09
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Grifols EUR 156.07M 31.46M 2025-09
Laboratory Of America USD 59.1M 2M 2026-09
Myriad Genetics USD 4.4M 600K 2025-12
Otsuka Holdings JPY 8.54B 6.32B 2026-09
Pfizer USD 662M 5M 2026-09
United Therapeutics USD 2.9M 0 2026-09